Clinical Trial Update: A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

View source ↗

Summary

A clinical trial update investigating eltrombopag in combination with recombinant human thrombopoietin for corticosteroid-resistant or relapsed immune thrombocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Corticosteroid-resistant or Relapsed ITP | Status: UNKNOWN | Results posted: 2020-10-20